Your Shopping Cart Is Empty
Continue Shopping
Latest Publications Upcoming Publications Company Profiles COPD and asthma devices, also known as pulmonary drug delivery devices, are used as a permanent treatment or rescue therapy for respiratory diseases and other related ailments. It is the most advanced mode of drug administration in which the drug is directly delivered to the lungs to provide a systemic effect.
1.1 Company Overview
1.2 Company Snapshot
1.3 Operating Business Segment
1.4 Business Performance
1.5 Key Strategic moves and Development
TABLE 1. GLAXOSMITHKLINE PLC SNAPSHOT
TABLE 2. GLAXOSMITHKLINE PLC OPERATING SEGEMENTS
FIG. 1. GLAXOSMITHKLINE PLC, REVENUE 2013-2015 ($MILLION)
FIG. 2. GLAXOSMITHKLINE PLC, REVENUE BY GEOGRAPHY 2015 (%)
FIG. 3. GLAXOSMITHKLINE PLC REVENUE BY BUSINESS SEGMENTS, 2015 (%)
FIG. 4. SWOT ANALYSIS OF GLAXOSMITHKLINE PLC
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers
PDF Format 